Fredericksburg, va, October 22, 2024 ― Mary Washington Hospital’s Structural Heart and Valve Clinic has again earned the highest three-star rating for its patient care and outcomes in Transcatheter Aortic Valve Replacement (TAVR), from the Society of Thoracic Surgeons (STS) and American College of Cardiology (ACC).
Mary Washington Hospital is also among the elite top five percent of all TAVR programs in the USA, and the only TAVR program in Virginia to receive this exclusive 3-star rating for three consecutive rolling periods from 2018-2023. This latest designation data analysis covers October 1, 2020 – September 30, 2023.
The STS star rating system is one of the most sophisticated and highly regarded overall measures of quality in health care, rating the benchmarked outcomes of cardiothoracic surgery programs across the United States and Canada. The 3-star rating for TAVR outcomes is calculated using a combination of quality measures for specific procedures.
Mary Washington Healthcare is proud to be recognized once again for delivering exceptional cardiac care that consistently results in positive outcomes for our patients,” said Mike McDermott, MD, MBA, President, and Chief Executive Officer, Mary Washington Healthcare. “Our unwavering dedication to meeting the healthcare needs of our community is supported by our advanced technology and outstanding clinical teams.”
TAVR is a minimally invasive procedure to replace the aortic valve in patients with severe aortic stenosis, which is a narrowing of the aortic valve opening which can cause chest pain, shortness of breath and fatigue due to limited blood flow. TAVR provides a unique option for patients to have a valve replacement without open heart surgery. Patients who have the TAVR procedure often spend just one day in the hospital and experience a quicker recovery than with traditional heart surgery. For more information, visit Heart.mwhc.com.